FTA:
A combination of human stem cell transplantation and antidiabetic drugs proved to be highly effective at improving body weight and glucose metabolism in a mouse model of type 2 diabetes. The findings could set the stage for clinical trials to test the first stem cell-based approach for insulin replacement in patients with type 2 diabetes.